Gregory Downey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gregory Downey
Earlier roles on record: CFO at Lexaria Bioscience Corp. (LEXX) until June 6, 2023. Lexaria Bioscience Corp. reported in an 8-K filed June 12, 2023 that Gregory Downey was terminated as Chief Financial Officer, effective June 6, 2023.
“Effective June 6, 2023, Mr. Gregory Downey was dismissed as the Company's Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-04-15–2023-06-06
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.